UCB Sues KV Pharmaceutical Over Generic Metadate
Belgian pharmaceutical giant UCB Inc. has slapped KV Pharmaceutical Co. with a patent infringement suit over the generics maker's plan for a generic version of UCB's attention deficit and hyperactivity disorder...To view the full article, register now.
Already a subscriber? Click here to view full article